Table 2 Characteristics of cohort I mother and infants enrolled in prospective follow-up, Uganda 2017–2019.

From: An impact evaluation of the national prevention of mother to child HIV transmission program and MTCT associated factors in Uganda 2017–2019

 

HIV-infected infants (col %)

HIV-uninfected infants (col %)

Total (col %)

Maternal characteristics

   

Maternal age (years) at enrollment

   

15–19

0 (0.0)

55 (5.2)

55 (5.2)

20–24

3 (42.9)

266 (25.1)

269 (25.2)

25 years and older

4 (57.1)

734 (69.3)

738 (69.2)

Missing

0 (0.0)

4 (0.4)

4 (0.4)

Highest education level

   

Tertiary/technical/university

0 (0.0)

23 (2.2)

23 (2.2)

Secondary, 5–6

0 (0.0)

15 (1.4)

15 (1.4)

Secondary, 1–4

1 (14.3)

224 (21.2)

225 (21.1)

Primary, 1–7

5 (71.4)

674 (63.6)

679 (63.7)

No education

1 (14.3)

122 (11.5)

123 (11.5)

Missing/unknown

0 (0.0)

1 (0.1)

1 (0.1)

Marital status

   

Never married

1 (14.3)

112 (10.6)

113 (10.6)

Married

5 (71.4)

775 (73.2)

780 (73.2)

Co-habitating

0 (0.0)

105 (9.9)

105 (9.9)

Missing

1 (14.3)

67 (6.3)

68 (6.4)

Health facility level

   

Hospital (general and regional referral hospital)

1 (14.3)

84 (7.9)

85 (8.0)

Health center IV

1 (14.3)

175 (16.5)

176 (16.5)

Health center III

1 (14.3)

311 (29.4)

312 (29.3)

Health center II

4 (57.1)

472 (44.6)

476 (44.7)

Clinic

0 (0.0)

17 (1.6)

17 (1.6)

Number of pregnancies

   

1

0 (0.0)

113 (10.7)

113 (10.6)

2–3

4 (57.1)

404 (38.2)

408 (38.3)

4–5

1 (14.3)

308 (29.1)

309 (29.0)

6 or more

2 (28.6)

192 (18.1)

194 (18.2)

Missing

0 (0.0)

42 (4.0)

42 (3.9)

Mother attended ANC

   

No

1 (14.3)

26 (2.5)

27 (2.5)

Yes

6 (85.7)

1033 (97.5)

1039 (97.5)

Place of delivery

   

Public facility

6 (85.7)

702 (66.3)

708 (66.4)

Private facility

1 (14.3)

216 (20.4)

217 (20.4)

Home

0 (0.0)

116 (11.0)

116 (10.9)

Missing

0 (0.0)

25 (2.4)

25 (2.4)

Birth attendee

   

Non-skilled

0 (0.0)

121 (11.4)

121 (11.4)

Skilled

7 (100)

938 (88.6)

945 (88.7)

Mother on ART

   

No

0 (0.0)

9 (0.9)

9 (0.8)

Yes

5 (71.4)

885 (83.6)

890 (83.5)

Missing

2 (28.6)

165 (15.6)

167 (15.7)

Ever virally non-suppressed (VL ≥ 1,000 copies/ml) during enrollment or follow-up

   

Yes

4 (57.1)

176 (16.6)

180 (16.9)

No

3 (42.9)

866 (81.8)

869 (81.5)

Missing

0 (0.0)

17 (1.6)

17 (1.6)

Infant characteristics

   

Age at enrollment

   

Less than 8 weeks

3 (42.9)

471 (44.5)

474 (44.5)

8 weeks or older

4 (57.1)

585 (55.2)

589 (55.3)

Missing

0 (0.0)

3 (0.3)

3 (0.3)

Birth weight

   

Less than 2.5 kg

0 (0.0)

67 (6.3)

67 (6.3)

2.5 kg or more

6 (85.7)

741 (70.0)

747 (70.1)

Missing

1 (14.3)

251 (23.7)

252 (23.6)

Nevirapine after birth

   

Yes

5 (71.4)

913 (86.2)

918 (86.1)

No

2 (28.6)

144 (13.6)

146 (13.7)

Missing

0 (0.0)

2 (0.2)

2 (0.2)

Infant feeding method last 7 days

   

Exclusively breastfed

4 (57.1)

941 (88.9)

945 (88.7)

Mixed feeding

3 (42.9)

104 (9.8)

107 (10.0)

Replacement feeding

0 (0.0)

6 (0.6)

6 (0.6)

Missing

0 (0.0)

8 (0.8)

8 (0.8)